On March 13, 2025, China SXT Pharmaceuticals, Inc. entered into a warrant exchange agreement, cancelling 28,400,000 warrants in exchange for 11,225,000 new ordinary shares valued at $0.66 each. This agreement was approved by the board and completed on March 18, 2025.